Sort
326,823 grants matching “clinical trial”
Delaney AIDS Research Enterprise to Cure HIV
$5,612,699Steven Grant Deeks · University Of California, San Francisco · UM1 · FY2021 · AI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$5,611,592S. Claiborne Johnston · University Of California, San Francisco · UL1 · FY2011 · RR
Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01)
$5,610,472Rose A Gubitosi-Klug · Case Western Reserve University · U01 · FY2017 · DK
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
$5,609,272Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2021 · AI
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
$5,608,768Duke University · P30 · FY2002 · CA
NIDA Clinical Trials Network: Big South/West Node (CTN-0132 and CTN-0139)
$5,606,566Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2025 · DA
Office of Cancer Nanotechnology Research
$5,606,139David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE
$5,604,602University Of Washington · U01 · FY2003 · AG
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$5,602,987Kimberly Wallace · Niaid Extramural Activities · Z01 · FY2007 · AI
Cancer Center Support Grant
$5,600,513Jennifer A Pietenpol · Vanderbilt University · P30 · FY2013 · CA
AIDS Malignancy Clinical Trials Consortium (AMC)
$5,600,000Ronald T Mitsuyasu · University Of California Los Angeles · U01 · FY2013 · CA
Development of Proteosome-adjuvanted nasal SARS vaccines
$5,599,999Id Biomedical Corporation Of Washington · UC1 · FY2004 · AI
Preclinical Development of Novel Dual OXR/KOR Antagonists for Treatment of Substance Use Disorder
$5,598,515John A Butera · Hager Biosciences, Llc · UF1 · FY2021 · DA
NIDA CTN BS/WN Yr16 S1 CTN0109-0110
$5,593,754Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2020 · DA
Insulin Resistance Intervention after Stroke Trial
$5,589,514Yale University · U01 · FY2004 · NS
Clinical and biomarker studies in Alzheimer's disease and related disorders
$5,587,710Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2023 · AG
UW Comprehensive Cancer Center Support
$5,586,470George Wilding · University Of Wisconsin-Madison · P30 · FY2006 · CA
UW Comprehensive Cancer Center Support
$5,586,470University Of Wisconsin Madison · P30 · FY2005 · CA
CHARACTERIZATION OF MPOX
$5,583,900Leidos Biomedical Research, Inc. · N01 · FY2025 · AI
SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
$5,583,692Fred Hutchinson Cancer Research Center · U10 · FY2001 · CA
Neuropathogenesis of Retroviral Infections
$5,580,007Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Neuropathogenesis of Retroviral Infections
$5,580,007Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Neuropathogenesis of Retroviral Infections
$5,580,007Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
THE VANDERBILT INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH (VICTR) UL1
$5,577,167Gordon R. Bernard · Vanderbilt University · UL1 · FY2011 · RR
Hosting, Maintenance and Professional services for Rave and Medidata Rave Integrated Software
$5,576,825Gregg Kravatz · · N02 · FY2018 · CA